The Next Generation of NeoTYPE™ Hematologic Disease and Solid Tumor Profiles
NeoTYPE Profiles have been enhanced to provide the widest spectrum of molecular profiles available ranging from highly focused to broad genomic coverage
Effective October 16, 2014, NeoTYPE Cancer Profiles have been expanded to include two additional broad pan-tumor profiles, the NeoTYPE Discovery Profile for Solid Tumors and the NeoTYPE Cancer Exome Profile. Combined with the other two intermediate pan-tumor profiles and the 21 cancer-specific NeoTYPE Profiles, NeoGenomics is ofers two unique levels of molecular profiling services that center on NGS based testing to fit all your needs. These two levels of services range from the more highly focused cancer-specific testing to wide spectrum tumor testing. Together these services encompass all areas of molecular profiling.
Another modification that allows clients more flexibility is the option to order Tech-Only. The majority of NeoTYPE Cancer Profiles can now have their FISH/Flow Cytometry testing be ordered as Tech-Only or Global. This update in conjunction with NeoGenomics’ ever-expanding menu aids in providing the best clinical opportunities for our clients.
Advantages of the NeoTYPE™ Next-Gen Cancer Profiles include
Click to see details of individual targeted Cancer-Specific Profiles or Broad Reach options for a pan-tumor approach.
NeoGenomics offers unprecedented flexibility in test-ordering by allowing clients to add tests to a standard, pre-configured Profile, or to choose tests individually outside the NeoTYPE™ ordering and reporting structure. In addition, pathology clients can choose the option of Tech-Only FISH and flow cytometry in our Cancer-Specific Profiles.
Adding to an Existing Profile
Individual Test Orders
Molecular Testing with FISH/Flow Cytometry Tech-Only Option for Pathologists